Guides
/
Gut Health

Stool Test Results: How to Read & Interpret

REVIEWED BY
William Maish, MD MBA MPH
Clinical Product Lead
Published
April 18, 2026
Last updated
June 4, 2026
Key takeaway:

Stool tests reveal three categories of digestive health data: infectious agents (bacteria, parasites, viruses), inflammatory markers such as calprotectin — where levels above 50 μg/g may suggest intestinal inflammation — and digestive function indicators like pancreatic elastase and fat content that reflect how well nutrients are being absorbed.

Read more →
Table of contents

What stool test results mean

Stool test results reveal three main categories of digestive health information. Infectious agents include bacteria like Salmonella or C. difficile, parasites such as Giardia, and viruses that may be associated with gastroenteritis. A positive result means these organisms are present and likely causing symptoms.

Inflammatory markers measure proteins released when your intestinal lining becomes irritated. Calprotectin levels above 50 micrograms per gram may suggest active inflammation. Lactoferrin, another inflammatory protein, may indicate immune system activation in your gut.

Blood detection comes in two forms: visible blood you can see, and occult (hidden) blood detected only through chemical testing. Both types may suggest bleeding somewhere in your digestive tract, from minor irritation to more serious conditions.

Digestive function tests measure how well you break down and absorb nutrients. Fat in stool (steatorrhea) may suggest pancreatic enzyme deficiency or bile acid problems. Low elastase levels may indicate poor pancreatic function.

How to interpret stool test results

Reading stool test results requires understanding reference ranges and clinical significance. Most testing reports show results as "negative," "positive," or provide numerical values with normal ranges.

For infectious agents, any positive result typically requires treatment. However, some people carry certain bacteria without symptoms (asymptomatic carriers). Your care team considers your symptoms alongside test results.

Inflammatory markers use numerical thresholds. Calprotectin below 50 μg/g is generally considered normal, 50-200 μg/g may suggest mild inflammation, and above 200 μg/g could indicate significant intestinal inflammation associated with conditions like inflammatory bowel disease.

Blood tests are binary: present or absent. Even trace amounts warrant investigation. The location and amount of bleeding determine urgency, but all positive results need medical evaluation.

Digestive enzymes have specific ranges. Pancreatic elastase below 200 μg/g may suggest pancreatic insufficiency. Fat content above 7 grams per day may indicate malabsorption.

What can influence stool test results

Multiple factors can skew stool test results, creating false positives or masking real issues. Dietary choices in the 72 hours before testing significantly impact results. Red meat, iron supplements, and vitamin C can affect blood detection tests.

Medications alter gut bacteria and inflammation markers. Antibiotics taken within 2-4 weeks can eliminate target bacteria, creating false negatives. NSAIDs (ibuprofen, naproxen) may be associated with intestinal bleeding and elevated inflammatory markers.

Sample collection timing matters crucially. Contamination with urine, toilet water, or menstrual blood invalidates results. Samples older than 24-48 hours may not accurately reflect bacterial populations.

Recent illness or stress can temporarily elevate inflammatory markers. Your immune system activation from any cause can increase calprotectin and lactoferrin levels, even without primary gut inflammation.

Probiotic supplements can introduce non-pathogenic bacteria that might be detected in some tests, though they rarely interfere with pathogen-specific testing.

Related context that changes the picture

Stool test results gain meaning when viewed alongside other health markers. Blood inflammatory markers like C-reactive protein and erythrocyte sedimentation rate (ESR) help distinguish local gut inflammation from systemic inflammation.

Nutrient absorption markers in blood work complement stool testing. Low vitamin B12, folate, or fat-soluble vitamins (A, D, E, K) may support stool findings of malabsorption. Iron deficiency anemia alongside positive occult blood may suggest chronic gastrointestinal bleeding.

Immune system markers provide additional context. Low IgA levels can predispose you to gut infections, while elevated eosinophils might suggest parasitic infections that stool testing may help identify.

Hormonal factors influence digestive function and test interpretation. Thyroid disorders affect gut motility and can alter stool consistency and transit time. Cortisol elevation from chronic stress impacts gut barrier function and inflammatory responses.

Food sensitivity testing may help explain persistent symptoms when stool tests are negative for pathogens but show inflammation. IgG food antibodies or elimination diet results can guide dietary modifications that may help reduce gut inflammation.

Take control of your digestive health

Understanding your stool test results is just the beginning. The real insight comes from seeing how your digestive markers connect with your overall metabolic and inflammatory status.

Superpower's comprehensive health panels include digestive health markers alongside complete blood biomarker analysis. You'll see how gut inflammation relates to your immune function, nutrient absorption, and metabolic health. This complete picture helps you and your care team make targeted interventions that address root causes, not just symptoms.

Explore Superpower's health testing options to get the full context your digestive health deserves.

FAQs

Stool samples can detect bacterial infections (like Salmonella, C. difficile, E. coli), parasites (such as Giardia, Cryptosporidium), viruses causing gastroenteritis, and signs of inflammatory bowel disease, bleeding, or digestive enzyme deficiencies.

Look for three main categories: infectious agents (positive means treatment needed), inflammatory markers (calprotectin above 50 μg/g suggests inflammation), and blood presence (any positive result needs medical evaluation). Compare numerical values to provided reference ranges.

Out-of-range findings include presence of harmful bacteria, parasites, or viruses; blood (visible or occult); elevated inflammatory markers like calprotectin above 200 μg/g; excess fat indicating malabsorption; or low pancreatic enzymes below 200 μg/g.

Stool tests can reveal infectious organisms, inflammatory markers (calprotectin, lactoferrin), blood presence, digestive enzyme levels, fat content, and sometimes food sensitivities. Results help detect infections, inflammatory conditions, bleeding, and malabsorption issues.

Calprotectin above 200 μg/g could indicate significant intestinal inflammation that may be associated with conditions like inflammatory bowel disease. Values between 50 and 200 μg/g suggest mild inflammation and typically warrant follow-up, while levels below 50 μg/g are generally considered normal.

Antibiotics taken within 2-4 weeks can eliminate target bacteria, creating false negatives. NSAIDs such as ibuprofen may be associated with intestinal bleeding and elevated inflammatory markers. Probiotic supplements can also introduce non-pathogenic bacteria that may appear on some tests.

References

  1. Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., Cantey, J., & Pickering, L. K. (2017). 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(12), 1963-1973. https://doi.org/10.1093/cid/cix959
  2. Rokkas, T., Portincasa, P., & Koutroubakis, I. E. (2018). Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis. Journal of gastrointestinal and liver diseases : JGLD, 27(3), 299-306. https://doi.org/10.15403/jgld.2014.1121.273.pti
  3. Khan, A. U., & Mandiga, P. (2023). Gastrointestinal bleeding scan. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK544317/
  4. González-Sánchez, V., Amrani, R., González, V., Trigo, C., Picó, A., & de-Madaria, E. (2017). Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis:. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 17(4), 580-585. https://doi.org/10.1016/j.pan.2017.03.002
  5. Roslani, A. C., Abdullah, T., & Arumugam, K. (2012). Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction. Asian Pacific journal of cancer prevention : APJCP, 13(1), 237-41. https://doi.org/10.7314/apjcp.2012.13.1.237
  6. Koch, K., Campanella, C., Baidoo, C. A., Manzo, J. A., Ameen, V. Z., & Kersey, K. E. (2004). Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex). Digestive diseases and sciences, 49(7-8), 1244-9. https://doi.org/10.1023/b:ddas.0000037819.31817.7c
  7. Philpott, H., Nandurkar, S., Lubel, J., & Gibson, P. R. (2013). Alternative investigations for irritable bowel syndrome. Journal of gastroenterology and hepatology, 28(1), 73-7. https://doi.org/10.1111/j.1440-1746.2012.07291.x
  8. Bathobakae, L., Rivera, E., Mücahit, D., John, R., Atogwe, I., Phuu, P., Escobar, J., Bandaru, P., Cavanagh, Y., Ligresti, R., & Robinson, M. K. (2026). Pancreatic Exocrine Insufficiency After Metabolic and Bariatric Surgery. Digestive diseases and sciences, 71(1), 95-108. https://doi.org/10.1007/s10620-025-09325-z
  9. Nicholson, M. R., Ma, S., Strickland, B. A., Cecala, M., Zhang, L., Reasoner, S., Guiberson, E. R., Munneke, M. J., Shilts, M. H., Skaar, E. P., & Das, S. R. (2026). The Gut Microbiome and Butyrate Differentiate Clostridioides difficile Colonization and Infection in Children. The Journal of infectious diseases, 233(3), e812-e822. https://doi.org/10.1093/infdis/jiaf631
  10. Jaffe, R. M., Kasten, B., Young, D. S., & MacLowry, J. D. (1975). False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Annals of internal medicine, 83(6), 824-6. https://doi.org/10.7326/0003-4819-83-6-824
  11. Higuchi, K., Umegaki, E., Watanabe, T., Yoda, Y., Morita, E., Murano, M., Tokioka, S., & Arakawa, T. (2009). Present status and strategy of NSAIDs-induced small bowel injury. Journal of gastroenterology, 44(9), 879-88. https://doi.org/10.1007/s00535-009-0102-2
  12. La Torre, D., Van Oudenhove, L., Vanuytsel, T., & Verbeke, K. (2023). Psychosocial stress-induced intestinal permeability in healthy humans: What is the evidence?. Neurobiology of stress, 27, 100579. https://doi.org/10.1016/j.ynstr.2023.100579
  13. Malícková, K., Kalousová, M., Fucíková, T., Bortlík, M., Duricová, D., Komárek, V., Zima, T., Janatková, I., & Lukás, M. (2010). Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes. Scandinavian journal of clinical and laboratory investigation, 70(4), 294-9. https://doi.org/10.3109/00365513.2010.485648
  14. Swain, S., Selmi, C., Gershwin, M. E., & Teuber, S. S. (2019). The clinical implications of selective IgA deficiency. Journal of translational autoimmunity, 2, 100025. https://doi.org/10.1016/j.jtauto.2019.100025
  15. Martínez-Vallejo, P., Mediavilla, A., Silgado, A., Zarzuela, F., Goterris, L., Maturana, C. R., Serre-Delcor, N., Oliveira-Souto, I., Salvador, F., Joseph-Munne, J., Aznar, M. L., Pou, D., Treviño, B., Molina, I., Sotillo, J., & Sulleiro, E. (2025). Evaluation of molecular and serological testing for imported urogenital schistosomiasis screening in a referral tropical medicine centre in Barcelona, Spain. Parasites & vectors, 18(1), 196. https://doi.org/10.1186/s13071-025-06832-w
  16. Kubiszewski, K., Chapman, R. W., Piazza, Y., Patel, D., & Neychev, V. (2023). Hypothyroidism Presenting as Adynamic Ileus Mimicking a Mechanical Small Bowel Obstruction: A Diagnostic and Management Dilemma. Cureus, 15(12), e50799. https://doi.org/10.7759/cureus.50799
  17. Klein, E. J., Stapp, J. R., Clausen, C. R., Boster, D. R., Wells, J. G., Qin, X., Swerdlow, D. L., & Tarr, P. I. (2002). Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. The Journal of pediatrics, 141(2), 172-7. https://doi.org/10.1067/mpd.2002.125908
  18. Johansen, Ø. H., Abdissa, A., Zangenberg, M., Mekonnen, Z., Eshetu, B., Bjørang, O., Alemu, Y., Sharew, B., Langeland, N., Robertson, L. J., & Hanevik, K. (2021). Performance and operational feasibility of two diagnostic tests for cryptosporidiosis in children (CRYPTO-POC): a clinical, prospective, diagnostic accuracy study. The Lancet. Infectious diseases, 21(5), 722-730. https://doi.org/10.1016/S1473-3099(20)30556-9

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey